We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

194 hedge funds and large institutions have $1.62B invested in Beam Therapeutics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 79 increasing their positions, 39 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 39

35% more call options, than puts

Call options by funds: $16.4M | Put options by funds: $12.2M

10% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 30

0.9% more ownership

Funds ownership: 84.24% → 85.14% (+0.9%)

0% more funds holding

Funds holding: 194 → 194 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

21% less capital invested

Capital invested by funds: $2.05B → $1.62B (-$428M)

Holders
194
Holders Change
–
Holders Change %
0%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
33
Increased
79
Reduced
39
Closed
30
Calls
$16.4M
Puts
$12.2M
Net Calls
+$4.21M
Net Calls Change
-$4.96M

Top Buyers

1
FCM
Farallon Capital Management
California
+$27.9M
2
Citadel Advisors
Citadel Advisors
Florida
+$23M
3
State Street
State Street
Massachusetts
+$14.9M
4
WP
Woodline Partners
California
+$12.1M
5
NAMA
Nikko Asset Management Americas
New York
+$11.4M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.2M
2
Morgan Stanley
Morgan Stanley
New York
-$8.39M
3
DTC
Deep Track Capital
Connecticut
-$8.09M
4
HRCM
Hood River Capital Management
Florida
-$8.04M
5
Goldman Sachs
Goldman Sachs
New York
-$7.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$211M +$10.8M +401,296 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$164M -$5.23M -195,009 -3%
BlackRock
3
BlackRock
New York
$157M +$4.61M +171,879 +3%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$156M -$17.2M -639,878 -9%
FCM
5
Farallon Capital Management
California
$108M +$27.9M +1,040,317 +30%
Temasek Holdings
6
Temasek Holdings
Singapore
$104M – – –
State Street
7
State Street
Massachusetts
$99.6M +$14.9M +555,125 +15%
MM
8
MWG Management
British Virgin Islands
$56.4M – – –
Sumitomo Mitsui Trust Group
9
Sumitomo Mitsui Trust Group
Japan
$39.5M +$11.4M +427,100 +35%
NAMA
10
Nikko Asset Management Americas
New York
$39.5M +$11.4M +427,100 +35%
RG
11
Redmile Group
California
$35.3M -$415K -15,474 -1%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$35.3M +$3.88M +144,573 +11%
Citadel Advisors
13
Citadel Advisors
Florida
$28.3M +$23M +857,371 +268%
DTC
14
Deep Track Capital
Connecticut
$24.4M -$8.09M -301,675 -23%
Baillie Gifford & Co
15
Baillie Gifford & Co
United Kingdom
$21.1M +$9.44M +352,014 +67%
HH
16
HSG Holding
Hong Kong
$19.1M – – –
BG
17
Bellevue Group
Switzerland
$16.7M -$16.1K -600 -0.1%
Pictet Asset Management
18
Pictet Asset Management
Switzerland
$16.6M +$18.6M +692,070 New
JP Morgan Chase
19
JP Morgan Chase
New York
$15.9M -$1.21M -45,125 -6%
Northern Trust
20
Northern Trust
Illinois
$15.7M +$795K +29,646 +5%
CC
21
Casdin Capital
New York
$13.7M – – –
YCM
22
Yiheng Capital Management
California
$13.5M +$2.59M +96,700 +21%
Charles Schwab
23
Charles Schwab
California
$13M +$1.07M +39,990 +8%
Morgan Stanley
24
Morgan Stanley
New York
$12.6M -$8.39M -313,063 -37%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$11.9M +$323K +12,060 +3%
1
2 3 4 5

BEAM Hedge Fund Activity: Q3 2023 in Review

194 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2023, worth a combined $1.62B — down 21% from $2.05B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BEAM positions and 30 closed out — a net gain of 3 holders — while 79 added to existing stakes and 39 trimmed.

The largest buyer was Farallon Capital Management, adding an estimated $27.9M. The largest seller was Fidelity Investments, cutting an estimated $17.2M.

  • 194 institutional investors held Beam Therapeutics (BEAM) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $1.62B of Beam Therapeutics stock for Q3 2023, down 21% quarter-over-quarter.
  • 33 funds opened new Beam Therapeutics positions in Q3 2023 and 30 closed out, a net change of +3 holders.
  • The largest Beam Therapeutics buyer in Q3 2023 was Farallon Capital Management, an estimated $27.9M added.
  • The largest Beam Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $17.2M sold.

Based on aggregated 13F filings for Q3 2023.